黄斑病:关于病理生理学,公共卫生和治疗的系统文献综述
Maria E Pantelidou1, David Sunnucks2, Elias P Pantelidis3
1Ophthalmology, James Paget University Hospital, Great Yarmouth, GBR.
Cureus
|January 1, 2025
概括
黄斑变性 (MD) 在所有年龄段都会导致严重的视力丧失. 目前的治疗方法只会延缓进展,强调需要改进的疗法,如干细胞治疗,以获得更好的患者结果.
科学领域:
- 眼科医生 眼科 眼科
- 遗传学 遗传学 是一个
- 视网膜疾病 视网膜疾病
背景情况:
- 黄斑变性 (MD) 是一种视网膜疾病,在所有年龄段都会导致严重的视力损伤.
- 与年龄相关的黄斑变性 (AMD) 是老年人视力丧失的主要原因.
- 斯塔格特病 (SD) 是最常见的遗传性黄斑病,通常以自体主导模式遗传.
研究的目的:
- 审查当前对黄斑变性 (MD) 的理解.
- 突出现有MD治疗方法的局限性.
- 强调开发新型治疗策略的必要性,包括干细胞疗法.
主要方法:
- 关于黄斑变性 (MD) 和其亚型的文献综述.
- 分析当前的治疗方式及其有效性.
- 讨论MD对患者和社会的影响.
主要成果:
- 现有的MD治疗方法,如抗VEGF注射,只能提供暂时的缓解,无法阻止疾病的进展.
- 黄斑发育不良会给患者带来严重的心理痛苦,并给社会带来财务负担.
- 视力受损严重影响患者的身体和精神健康.
结论:
- 目前对黄斑变性 (MD) 的管理策略不足以防止疾病的进展.
- 需要先进的治疗方法,包括干细胞疗法,以改善MD患者的预后.
- 对新型治疗方法的进一步研究对于改善受黄斑发育不良影响的个体的生活质量至关重要.
关键词:
成人发病的foveo-macular vitelliform dystrophy是一种发病在成年人身上的病变.医疗保健的可持续性黄斑病变是一种病变.身体和心理的福祉.斯塔加特病是斯塔加特病的一种疾病.进行干细胞移植.视力受损 视力受损 视力受损更多相关视频
09:24A Protocol to Evaluate and Quantify Retinal Pigmented Epithelium Pathologies in Mouse Models of Age-Related Macular Degeneration
Published on: March 10, 2023
1.4K
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.0K
相关概念视频
Lethal Alleles
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Overview of the Vascular System
The vascular system comprises an extensive network of arteries, capillaries, and veins. The vascular system can be broadly divided into the blood and lymphatic systems. Typically, blood vessels can be categorized into three histological regions: tunica intima, tunica media, and tunica adventitia. The tunica intima consists of a single layer of endothelial cells attached to the basal lamina. Underlying the basal lamina is a connective tissue layer and an elastic lamina that gives stability and...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Jaundice
Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
